FEMY

4.97% 0.0296

Handel nachbörslich: .62 -0.0046 -0.74%

Femasys Inc (FEMY)

Überblick Nachrichten Preisverlauf Financials Warum fällt FEMY? Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Femasys Inc Stock (FEMY) Company Profile

Healthcare (1116)

770-500-3910

3950 JOHNS CREEK COURT, SUWANEE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

FEMY's Discussions on Twitter

Vergleichen Sie FEMY mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FEMY Femasys Inc	0.6246	35.40M	950.10K	-16.69M	-15.16M	-0.83
ISRG Intuitive Surgical Inc	592.27	210.16B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	202.71	58.51B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	81.02	40.19B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	248.21	36.37B	5.26B	1.44B	1.76B	9.7713
MDLN Medline Inc	40.43	31.30B	27.43B	1.27B	1.01B	1.5829

Femasys Inc Stock (FEMY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-20	Eingeleitet	Laidlaw	Buy

Femasys Inc Aktie (FEMY) Neueste Nachrichten

Finanzdaten der Femasys Inc-Aktie (FEMY)

Femasys Inc (FEMY)

Femasys Inc Stock (FEMY) Company Profile

Vergleichen Sie FEMY mit anderen Aktien

Femasys Inc Stock (FEMY) Upgrades & Downgrades

Femasys Inc Aktie (FEMY) Neueste Nachrichten

How Femasys Inc. stock reacts to inflationary pressures2026 world cup usa national team group stage goalkeepers counter attacking expert forecast guide - ulpravda.ru

Earnings Beat: Will MARZ stock keep high P E multiples2025 Biggest Moves & Pattern Based Trade Signal System - moha.gov.vn

Femasys gains UK approval for women's health products - MSN

Market Leaders: How strong is Femasys Inc stock balance sheetQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - moha.gov.vn

User | theeveningleader.comFemasys Inc.Common Stock (Nasdaq:FEMY) Stock Quote - FinancialContent

Femasys files for at-the-market offering of up to $9.8 million in common stock - Investing.com India

Femasys Launches At-the-Market Common Stock Offering - TipRanks

Femasys files for at-the-market offering of up to $9.8 million in common stock By Investing.com - Investing.com South Africa

Femasys Inc Files Prospectus for Stock Offering - TradingView — Track All Markets

Suwanee company Femasys Inc. gets FDA approval for diagnostic device - The Business Journals

Will Femasys Inc. stock maintain growth story2025 Market Sentiment & Target Return Focused Stock Picks - Улправда

Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more - Contemporary OB/GYN

Swing Trade: Why Femasys Inc. stock is a must watch in 20252025 Geopolitical Influence & Accurate Intraday Trading Signals - Улправда

What momentum indicators show for Femasys Inc. stockMarket Sentiment Review & Risk Managed Trade Strategies - Bölüm Sonu Canavarı

Why Femasys Inc. stock is rated strong buyJuly 2025 Momentum & Real-Time Volume Spike Alerts - Улправда

Femasys receives FDA clearance for FemVue Controlled diagnostic device By Investing.com - Investing.com Australia

How interest rate cuts could boost Femasys Inc. stockMarket Growth Review & Technical Entry and Exit Tips - Bölüm Sonu Canavarı

How strong is Femasys Inc. stock balance sheet2025 Trading Recap & Consistent Profit Focused Trading Strategies - DonanımHaber

Why Femasys Inc. stock is a must watch in 20252025 Market Sentiment & Growth Oriented Trade Recommendations - Улправда

What analyst consensus says on Femasys Inc. stockJuly 2025 Action & AI Powered Market Trend Analysis - DonanımHaber

Femasys Earnings Notes - Trefis

PharmaCyte Biotech (Nasdaq: PMCB) reports Q2 loss and details QCLS, Femasys deals - Stock Titan

Femasys Inc. Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device - marketscreener.com

FDA clears FemVue Controlled for in-office tubal assessment - Contemporary OB/GYN

Femasys secures U.S. FDA clearance for next-generation Femvue diagnostic device - marketscreener.com

Femasys Gains FDA Clearance for FemVue Diagnostic Device - TipRanks

Femasys gains FDA clearance for FemVue diagnostic device - MSN

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device - The Manila Times

Femasys Inc Secures FDA Clearance for FemVue Diagnostic Device - TradingView — Track All Markets

Femasys (NASDAQ: FEMY) secures FDA clearance for next-generation FemVue diagnostic - Stock Titan

Femasys receives FDA clearance for FemVue Controlled diagnostic device - Investing.com

Femasys Inc. Receives FDA Clearance for Innovative FemVue Controlled Device to Enhance Fallopian Tube Evaluation and Workflow Efficiency - Quiver Quantitative

New device could make fallopian tube testing simpler for fertility care - Stock Titan

PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN

Femasys Secures Major Order for FemBloc Launch - MSN

Femasys Receives FDA Approval for FemBloc Trial - MSN

FDA Approves Final Trial Phase for Femasys’ Permanent Birth Control Product - Medical Product Outsourcing

PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade

PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com

Femasys Inc Stock Analysis and ForecastTechnical Breakout Signals & Minimal Capital Trading - earlytimes.in

CapEx per share of Femasys Inc. – NASDAQ:FEMY - TradingView

Femasys (NASDAQ:FEMY) Rating Increased to Hold at Wall Street Zen - MarketBeat

PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN

Energy Moves: Why Femasys Inc. stock is a must watch in 2025Weekly Investment Report & Community Verified Trade Alerts - moha.gov.vn

PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria

PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia

Finanzdaten der Femasys Inc-Aktie (FEMY)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie FEMY